Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

UCITS Alternative Index Global up 0.32% in November (1.13% YTD)

Monday, December 03, 2012
Opalesque Industry Update - Here is the monthly performance review of the UCITS Alternative Index series as of November 2012.

UAI Benchmarks: The UCITS Alternative Index Global is up 0.32% in November and up 1.13% since the beginning of the year. The UCITS Alternative Funds of Funds is also up 0.11% this month but is still down -1.78% on year to date. All but three strategies return positive performance in November. The best performing strategies are the UAI Emerging Markets, up 0.73%, followed by UAI Multi-Strategy and the UAI Macro, up respectively 0.71% and 0.42%. The UAI FX is the worst performing benchmark with -0.24% in November, followed by the UAI Commodities with -0.22%. So far this year, the UAI Fixed Income is the best performer, up 4.44%, followed by the UAI Emerging Markets, up 4.02%.

UAI Blue Chip: The UAI Blue Chip is up 0.23% in November and up 4.25% on year to date. The positive monthly performance is mainly due to gains from Emerging Markets, Event-Driven and Multi-Strategy funds, while Commodities and Volatility funds perform slightly negatively.

UAIX Indices: Almost all UAIX indices are up in November. The UAIX Long/Short Equity is the best performer, up 0.58%. It is followed by the UAIX Emerging Markets (up 0.56%) and the UAIX Event-Driven (up 0.49%). The UAIX Equity Market Neutral and UAI CTA are down -0.19% and -0.14%. With the exception of CTA and Emerging Markets all UAIX indices outperform their UAI benchmarks. So far this year the UAIX Volatility displays the best performance with a gain of 7.04, followed by the UAIX Fixed Income - Developed Markets up 6.81%.

The UCITS Alternative Index Blue Chip and UAIX are model-based investable indices of UCITS hedge funds.

Press release

Full performance table: www.ucits-alternative.com

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for